<?xml version="1.0" encoding="UTF-8"?>
<ref id="B29-vaccines-07-00046">
 <label>29.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Du</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Kou</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Ma</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Tao</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Tseng</surname>
    <given-names>C.T.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>Y.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines</article-title>
  <source>PloS ONE</source>
  <year>2013</year>
  <volume>8</volume>
  <elocation-id>e81587</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0081587</pub-id>
  <pub-id pub-id-type="pmid">24324708</pub-id>
 </element-citation>
</ref>
